Aim. To in ves ti gate the ef fects of com bined hor mone re place ment ther apy (HRT) on the vas cu lar im ped ance of the uter ine, in fe rior ves i cle, and oph thal mic ar tery. Methods. Thirty-five postmenopausal pa tients were di vided in two groups: 21 pa tients with 1-5 years of menopause and 14 pa tients with ≥6 years of meno pause. Each group was ex am ined in basal con di tion and af ter 1, 3, and 6 months of HRT. The blood flow im ped ances of the uter ine, in fe rior ves i cle, and oph thal mic ar ter ies were an a lyzed by color Dopp ler. Estradiol plasma con cen tra tions were as sayed on the day of Dopp ler ex am i na tion. Re sults. The anal y sis of uter ine and in fe rior ves i cle ar tery flow ve loc i ties showed a sig nif i cant pos i tive cor re lation be tween the re sis tance in dex (RI) and years of meno pause. Higher im ped ance val ues were found in patients with lon ger in ter val from last men strual bleed ing (p<0.05). In pa tients with ≥6 years of meno pause, the im ped ances of uter ine and in fe rior ves i cle ar ter ies were 0.94±0.03 and 0.91±0.04, re spec tively, whereas in patients with 1-5 years of meno pause the im ped ances were 0.89±0.04 and 0.98±0.02, re spec tively. We no ticed no sig nif i cant cor re la tion be tween base line RI and du ra tion of meno pause at the level of oph thal mic ar tery in either group (0.72 vs. 0.73, re spec tively; p<0.05). Af ter six months of HRT, plasma estradiol con cen tra tions inversely cor re lated with RI of uter ine (r=0.2556; p=0.021), in fe rior ves i cle (r=0.2653; p=0.023) and oph thal mic (r=-0.2211; p=0.017) ar ter ies. Con clu sion. Dopp ler stud ies of uter ine, in fe rior ves i cle, and oph thal mic ar ter ies can pro vide spe cific and precise pathophysiological in for ma tion to as sess blood flow vari a tions in cor re la tion with com bined HRT.
Es tro gen loss in meno pause in duces va so mo tor symp toms and gen i tal at ro phy in postmeno pausal women (1) . Lower uri nary tract symp toms are also widely con sid ered to ac com pany meno pause. Since ste roid re cep tors have been lo cated in the struc tures in volved in micturition (2) , it is as sumed that these uri nary symp toms de pend on con cen tra tions of sex hor mones. Spe cifically, es tro gen and pro ges ter one re cep tors have been de tected in the fe male pel vic floor mus cles, uro gen i tal lig a ments, blad der, trigone, and ure thra (3) .
Fur ther more, a long-term postmenopausal estro gen de pri va tion was proved to be a risk fac tor for car dio vas cu lar and/or cerebrovascular dis ease (4) . Ob ser va tional clin i cal stud ies have re peat edly shown fa vor able as so ci a tions be tween hor monal replace ment ther apy (HRT) and meno pausal symptoms. Two meta-analyses in di cated a 50% re duc tion in vas cu lar dis ease risk in post meno pausal women on hor monal re place ment the rapy (4, 5) . There are sev eral mech a nisms whereby hor monal re placement ther apy can af fect the vas cu lar sys tem and all of them have both the met a bolic and di rect ef fects on ar ter ies. The aim of this study was to in ves ti gate di rect in flu ence of hor monal re place ment ther apy on the vas cu lar sys tem. Uter ine ar tery and in fe rior ves i cle ar tery were used to as sess the changes in uro gen i tal sys tem, whereas oph thal mic ar tery was a rep re sen ta tive of ce re bral cir cu la tion.
Subjects and Methods

Sub jects
Be tween Jan u ary 1999 and Jan u ary 2000, 35 women of postmenopausal age at tend ing Gynecological Endocrinological Clinic vol un tarily par tic i pated in our study. The ultra sonographer per form ing the ex am i na tion se lected all the par tici pants at ran dom.
All women were in good health with out any his tory of gynecological prob lems (uter ine or adnexal masses), hy perten sion, di a be tes, thy roid or re nal dis ease, cerebro-and/or car dio vas cu lar dis ease, glau coma, or eye sur gery. Non had pre vi ously taken any hor monal re place ment ther apy and all had had their last men strual bleed ing at least 12 months before en ter ing our study (me dian du ra tion of meno pause was 35 months, range 12-144). Their age ranged from 47-59 year (mean 53.4), and se rum FSH con cen tra tions were at least 30 IU/L (mean 47±16 IU/L).
The mean body mass in dex of the par tic i pants was 25.1±3.7 (kg/m 2 ), the sys tolic blood pres sure was 119±13 mmHg, and di a stolic 77±10 mmHg.
The Hos pi tal Eth ics Re view Com mit tee ap proved the study pro to col, and all the pa tients gave in formed con sent.
Af ter a base line check-up, in clud ing trans vaginal ul trasound and color Dopp ler scan, pa tients were di vided into two groups ac cord ing to the du ra tion of meno pause, and were admin is tered hor monal re place ment ther apy orally. Twenty-one pa tients, whose last men strual bleed ing was 1-5 years ago, were pre scribed Trisequens (Novo Nordisk, Bagsevaerd, Denmark), whereas 14 pa tients in meno pause lon ger than 6 years were pre scribed Kliogest (Novo Nordisk). Trisequens is admin is tered orally and con tains hu man estrogens (2 mg E2, 1 mg estriol) com bined with only 10 days of pro ges ter one (1 mg norethisterone ac e tate) per month. Kliogest is an es trogen-progesterone com bi na tion (2 mg E2, 1 mg norethisterone ac e tate).
The pa tients were stud ied in basal con di tion and af ter 1, 3, and 6 months of hor monal re place ment ther apy.
Color Dopp ler Anal y sis All pa tients un der went transvaginal ul tra sound ex am ina tion of the pel vic or gans. Dopp ler flow mea sure ments of the uter ine and in fe rior ves i cle ar tery were per formed.
We used Aloka Color Dopp ler SSD 2000 (Aloka, To kyo, Ja pan) with a 5-MHz transvaginal probe for im ag ing and 6 MHz pulsed Dopp ler sys tem for color vi su al iza tion of blood flow. Pulsed rep e ti tion fre quen cies ranged from 2 to 42 kHz. The spa tial peak tem po ral av er age range in ten sity was approx i mately 80 mW/cm 2 . Wall fil ters (50 Hz) were used to elim i nate low fre quency sig nals of noise. Af ter void ing, the pa tient as sumed the lithotomy po si tion and the probe was inserted into the pos te rior fornix of the va gina. Mor phol ogy of the adnexa was ex plored by B-mode sonography. The color sig nal from the main uter ine ar ter ies could be seen lat er ally to the cer vix in a lon gi tu di nal plane. In fe rior ves i cle ar tery was stud ied when the re sid ual blad der vol ume was un der 30 mL. Af ter vi su al iz ing the ure thra and blad der neck in the midline, the probe was di rected lat er ally and ro tated for 15 un til the base of blad der ap peared. The ves sel run ning from the pel vis side along the blad der base to wards the blad der neck was the in fe rior vesical ar tery.
To an a lyze the oph thal mic ar tery, lin ear trans ducer (7.5 MHz) was placed on the closed eye lids of a pa tient af ter apply ing cou pling gel. The pa tient was in structed to turn the eyes to the contralateral side due to the refractivity of the eye lenses. The probe was ap plied with out pres sure in the an terior-posterior di rec tion. The oph thal mic ar tery was iden ti fied as larger-caliber pulsatile ves sel typ i cally ad ja cent to the op tic nerve (su pe ri orly and me di ally). When we re ceived good signals, we re corded the re sis tance in di ces by plac ing the sample vol ume across the ves sel and en ter ing the pulsed mode.
To en sure stan dard ized con di tions, all pa tients rested for at last 15 min utes be fore scan ning, and to avoid cir ca dian vari a tions in ar tery blood flow, all pa tients were ex am ined between 8:00 and 11:00 a.m. A re cord ing was re garded sat is factory when there were at least five con sec u tive wave forms, each show ing a max i mum Dopp ler shift. Re sis tance in dex, RI [peak sys tolic ve loc i ties -peak di a stolic ve loc i ties/peak systolic ve loc i ties], was cal cu lated from three con sec u tive uniform heart beats. Since no sig nif i cant dif fer ences be tween Dopp ler pa ram e ters of the left and right side were ob served, we used the av er age value of both ar ter ies. The repro ducibility of Dopp ler mea sure ments was tested in 10 pa tients, whose re sis tance in dex was mea sured three times at 10 minutes in ter vals by the same op er a tor and an a lyzed by the analy sis of vari ance. The co ef fi cient of vari a tion was 6.5% and the av er age du ra tion of the pro ce dure was 30 min utes.
Hor mone As say Pe riph eral blood was ob tained from the pa tients between 8:00 and 11:00 a.m. on the day of im ag ing and Dopp ler ex am i na tions.
Estradiol con cen tra tions were de ter mined with a microparticle en zyme immunoassay (MEIA) (Abbott Di agnos tics, Chi cago, MI, USA).
Sta tis ti cal Analysis
We used Stu dent's t-test and anal y sis of vari ance for the sta tis ti cal anal y ses. The re la tion ship be tween the pa ram e ters was as sessed with the lin ear re gres sion method. Prob a bil ity of 0.05 was con sid ered sta tis ti cally sig nif i cant.
Results
We no ticed a sig nif i cant cor re la tion be tween the base line re sis tance in dex of the uter ine ar ter ies and the du ra tion of meno pause. Higher im pedance val ues were ob tained in pa tients who were in meno pause ≥6 years, than in pa tients 1-5 years in meno pause (0.94±0.03 vs. 0.89±0.04; p<0.05). The vi su al iza tion rate of the uter ine ar ter ies in both groups was 100%.
Ab sent di a stolic flow in uter ine ar ter ies was found in 3 (15.0%) pa tients with 1-5 years du ration of meno pause, and in 5 (35.7%) pa tients with ≥6 years meno pause pe riod. In tro duc tion of hormonal re place ment ther apy sig nif i cantly low ered the uter ine ar tery re sis tance in dex (p<0.05) in both groups of pa tients. Af ter the first month treat ment, the uter ine ar tery re sis tance in dex showed hav ing sta ble val ues, and no dif fer ences in the ef fec tiveness of hor monal re place ment ther apy were observed in women who be gan with hor monal re place ment 6 or more years af ter meno pause (p<0.05) (Fig. 1) . Vi su al iza tion rate of clear Dopp ler sig nals of the in fe rior vesical ar ter ies was 71.4% in postmenopausal pa tients in whom last men strual bleed ing oc curred 1-5 years be fore the stady. In the group of postmenopausal pa tients, in whom the last men strual bleed ing oc curred ≥6 years ago, the vi su al iza tion rate of in fe rior ves i cle ar tery was only 50% (p<0.05). Fur ther more, this group of patients showed sig nif i cantly higher in fe rior vesical ar tery re sis tance then postmenopausal pa tients in whom meno pause oc curred be fore 1-5 years (0.91±0.04 vs. 0.98±0.02; p<0.05). Higher vi su aliza tion rates for in fe rior vesical ar ter ies in both groups were dem on strated af ter the first month of hor monal re place ment ther apy. In ad di tion, in both groups blood flow ve loc ity wave forms were char ac ter ized with de creased re sis tance in dex values af ter the first month of treat ment when compared with the base line val ues (p<0.05), and remained un changed in the fol low ing mea surements (Fig. 2) .
In the oph thal mic ar ter ies, no sig nif i cant corre la tion be tween base line re sis tance in dex and the du ra tion of meno pause was no ticed in ei ther group (p<0.05). Vi su al iza tion of clear Dopp ler signals was pos si ble in all 35 pa tients, show ing no inter rup tion of di a stolic blood flow in oph thal mic ar ter ies. Fur ther more, blood flow in the oph thalmic ar tery in creased dur ing the hor monal re placement ther apy, but a sig nif i cant de crease in re sistance in dex was ob served not sooner than af ter 6 months of ther apy (p<0.001). There were no dif ferences in the ef fec tive ness of hor monal re placement ther apy be tween the two pa tient groups (p<0.05).
The estradiol val ues changed as in di cated in Fig 4. Plasma estradiol con cen tra tions cor re lated inversely with RI of uter ine (r=0.2556; p=0.021), infe rior vesical (r=0.2653; p=0.023), and oph thalmic (r=-0.2211; p=0.017) ar ter ies.
Discussion
Apart from hor monal re place ment ther apyinduced changes in the lipids pro file, car bo hydrate and homocysteine me tab o lism, and fibrinolysis, much at ten tion has been given to the alter ations in ar te rial tone and blood flow in the context of hor monal re place ment ther apy. Ar te rial vasodilatation is the most typ i cal re ac tion to acute es tro gen ad min is tra tion (5) .
Our study showed that in creas ing age re duces uter ine blood flow and blood flow to the blad der neck. Blood flow re sis tance in di ces in both uter ine and in fe rior vesical ar ter ies were age-and es trogen-dependent.
Uter ine and in fe rior vesical ar tery flow ve locity anal y ses re vealed sig nif i cant pos i tive cor re lations be tween the re sis tance and du ra tion of meno pause. Fur ther more, plasma es tro gen concen tra tions cor re lated in versely to re sis tance in dices af ter the on set of hor monal re place ment therapy. We showed that uter ine and blad der neck envi ron ment could be eas ily ma nip u lated dur ing the meno pausal years by a proper hor monal stim u lation, since a rapid and pro found uter ine vas cu lar blood flow re sponse to hor monal re place ment ther apy was ob served. Changes in the Dopp ler signal pat tern of uter ine and in fe rior vesical ar tery flow, ob served in our study as a re sponse to hormonal re place ment ther apy, in di cated a pro found de crease in vas cu lar re sis tance. Knowing the effect of cir ca dian vari a tions in uter ine ar tery blood 4 . Vari a tions of plasma estradiol con cen tra tions (pg/mL) ob served dur ing the study pe riod.
Fig ure 3.
Blood flow in the oph thal mic ar tery ex pressed as re sis tance in dex (RI) be fore and 1, 3, and 6 months after hor monal re place ment ther apy (HRT). Tri an gles, >6 years of postmenopause; bars, 1-5 years of postmenopause. Sta tis ti cal sig nif i cance was reached in both groups (p<0.001 anal y sis of vari ance) af ter 6 months of ther apy.
Fig ure 2.
Blood flow in the in fe rior vesical ar tery blood flow, ex pressed as re sis tance in dex (RI), in postmenopausal pa tients in basal con di tion and af ter 1, 3, and 6 months of hor monal re place ment ther apy (HRT). Triangles, ≥6 years of postmenopause; bars, 1-5 years of post meno pause. The RI sig nif i cantly de creased in both groups af ter the first month of ther apy (p<0.05 anal y sis of vari ance) and re mained sta ble un til the end of the treat ment.
flow in postmenopausal women (6), we per formed all the mea sure ments be tween 8:00 and 11:00 a.m. Find ings in our study are in ac cor dance with some other stud ies (7) (8) (9) . The pos si bil ity to ma nipu late the uter ine en vi ron ment by hor monal treatment and to as sess its ef fects by color Dopp ler pres ents a chal lenge in the field of in fer til ity because of the in creased trend of later re pro duc tion (10) . Of course, not all Dopp ler stud ies showed the ben e fit of hor monal re place ment ther apy on uterine blood flow in postmenopausal women. For exam ple, Žalud et al (11) showed that con tin u ous hor monal re place ment ther apy sig nif i cantly in fluenced the thick ness of the postmenopausal endometrium but not the myometrium or the uter ine ar tery blood flow.
The lower uri nary tract is known to be es trogen sen si tive, but a di rect causal in flu ence of ag ing (meno pause) is not easy to dem on strate.
In our study, we showed a sig nif i cant de crease in the vi su al iza tion rates of in fe rior vesical ar tery with the du ra tion of meno pause. Af ter the first month of hor monal re place ment ther apy, these find ings sig nif i cantly im proved. No dif fer ences were ob served in women who be gan hor monal replace ment ther apy sev eral years af ter the on set of meno pause. There fore, the hor monal re place ment ther apy ef fect on lower uri nary tract may be con sidered ef fec tive even when started af ter the be gin ning of meno pause. In spite of its es tro gen sen si tiv ity and six months of ther apy, the vi su al iza tion rates of in ferior vesical ar tery did not reach 100%.
In our opin ion, se verely dam aged blad der neck ves sels may not be able to re spond to hormone re place ment ther apy in the same way as normal vasculature, which might be im por tant in treat ing postmenopausal uri nary symp toms by hor mones. Es tro gen re place ment ther apy, as part of the phar ma co log i cal man age ment in treat ing uri nary symp toms, is still a mat ter of con tro versy. One of the re cent stud ies (12) showed a sig nif i cant in crease in blad der wall thick ness, which cor related pos i tively with cir cu lat ing plasma estradiol con cen tra tions. Fur ther more, sig nif i cant im provements in sub jec tive uri nary symptomatology were ob served in 90% of the pa tients. On the other hand, some other stud ies (14, 15) , like the ma jor ity of ran dom ized con trolled tri als on es tro gen in treat ment of uri nary in con ti nence, have not shown sig nif i cant im prove ments in the prev alence of the sub jec tive symp toms (16) .
We also an a lyzed ves sel wall func tion of the oph thal mic ar tery, a rep re sen ta tive of the ce re bral cir cu la tion. Dopp ler ex am i na tion of oph thal mic ar tery was a tech nique easy to per form and our data showed that hor monal re place ment ther apy was ef fec tive in ame lio rat ing the ce re bral flow in healthy postmenopausal pa tients. We found no dif fer ences be tween base line re sis tance in dex and the du ra tion of meno pause, which showed the oph thal mic ar tery less es tro gen sen si tive than uter ine or vesical in fe rior ar tery. Sta tis ti cal sig nif icance of the es tro gen-mediated changes in ophthal mic ar tery was reached, but later than in in ferior vesical and uter ine ar ter ies. An other study reported sim i lar find ings (17) , whereas other authors, who ob served the changes in the ce re bral microcirculation in the cen tral ret i nal ar tery, did not find such changes in the oph thal mic ar tery of postmenopausal pa tients on estradiol ther apy (18, 19) . In our opin ion, the oph thal mic ar tery is use ful in mon i tor ing hor monal re place ment therapy ef fects on ce re bral per fu sion, since it is eas ily ac ces si ble brain ar tery.
In con clu sion, transvaginal color Dopp ler can be used as an eas ily ap pli ca ble, non-invasive tool for mon i tor ing the ef fi cacy of hor monal re placement ther apy in postmenopausal women by quanti fi ca tion of blood flow through the uter ine, vesical in fe rior, and oph thal mic ar ter ies.
